MarketCap
Facebook
X
Telegram
Land |
 Deuschland |
IPO-Jahr |
2018 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
34.3 M |
Marktkapitalisierung |
$ 254 M |
EBITDA (LTM) |
$ -964 M |
P/E (LTM) |
- |
P/S (LTM) |
0.25 |
EPS (LTM) |
-28.61 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.69 | 11.43 % | $ 73.6 M | Nasdaq Global Market | Britain |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market |  China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Seer
SEER
|
$ 1.63 | 0.18 % | $ 90.4 M | Nasdaq Global Select Market |  USA |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Stoke Therapeutics
STOK
|
$ 26.51 | 1.69 % | $ 1.57 B | Nasdaq Global Select Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 9.57 | 4.08 % | $ 81.3 M | Nasdaq Global Select Market | USA |
 |
Silence Therapeutics plc
SLN
|
$ 19.73 | 0.03 % | $ 2.8 B | Nasdaq Global Select Market | Britain |
 |
Taysha Gene Therapies
TSHA
|
$ 4.34 | 6.11 % | $ 1.39 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.34 | 0.54 % | $ 1.76 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 46.46 | 8.78 % | $ 35.6 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 26.14 | -2.24 % | $ 1.48 B | Nasdaq Global Select Market,SPB | USA |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Savara
SVRA
|
$ 4.82 | 9.93 % | $ 1.07 B | Nasdaq Global Select Market | USA |
 |
Viking Therapeutics
VKTX
|
$ 26.86 | 4.15 % | $ 3.03 B | Nasdaq Capital Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
TG Therapeutics
TGTX
|
$ 59.78 | 3.1 % | $ 8.63 B | Nasdaq Capital Market | USA |
 |
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | USA |
 |
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.37 | 4.66 % | $ 568 M | Nasdaq Global Select Market |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
- | 2.07 % | $ 34.4 M | Nasdaq Capital Market | USA |
 |
Cerecor Inc.
CERC
|
- | -1.68 % | $ 283 M | Nasdaq Capital Market | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
- | - | $ 1.63 B | Nasdaq Global Select Market | USA |
 |
Auris Medical Holding Ltd.
EARS
|
- | -1.77 % | $ 39.2 M | Nasdaq Capital Market |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
- | 0.34 % | $ 2.98 B | Nasdaq Global Select Market,SPB | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
- | 1.3 % | $ 27.7 M | Nasdaq Global Select Market |  France |
 |
GW Pharmaceuticals plc
GWPH
|
- | - | $ 6.81 B | Nasdaq Global Select Market | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
- | - | $ 1.7 B | Nasdaq Global Select Market | USA |
 |
Liminal BioSciences
LMNL
|
- | - | $ 256 M | Nasdaq Global Market | Canada |
 |
argenx SE
ARGX
|
$ 928.5 | 3.77 % | $ 56.9 B | Nasdaq Global Select Market |  Niderland |
|
XBiotech
XBIT
|
$ 1.88 | 0.53 % | $ 57.3 M | Nasdaq Global Select Market | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
- | -2.54 % | $ 57.2 M | Nasdaq Global Market | USA |
 |
Xencor
XNCR
|
$ 36.19 | 6.28 % | $ 2.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
- | -3.18 % | $ 58.5 M | Nasdaq Global Select Market | USA |
 |
Orphazyme A/S
ORPH
|
- | -2.25 % | $ 31.3 M | Nasdaq Global Select Market |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
- | -10.74 % | $ 89.9 M | Nasdaq Global Select Market | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Xenetic Biosciences
XBIO
|
$ 1.87 | 0.31 % | $ 3.18 M | Nasdaq Capital Market | USA |
 |
Translate Bio, Inc.
TBIO
|
- | - | $ 2.81 B | Nasdaq Global Select Market,SPB | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
- | - | $ 1.94 B | Nasdaq Capital Market | Canada |
 |
Exicure
XCUR
|
$ 0.91 | 2.77 % | $ 5.73 M | Nasdaq Capital Market | USA |
 |
Urovant Sciences Ltd.
UROV
|
- | - | $ 532 M | Nasdaq Global Select Market | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
- | - | $ 10.9 B | Nasdaq Global Market,SPB | USA |